Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
46.395(c) 47.895(c) 47.61(c) 48.685(c) 49.145(c) Last
3 537 630 4 592 054 3 079 401 3 492 135 4 262 711 Volume
-2.26% +3.23% -0.60% +2.26% +0.94% Change
More quotes
Financials
Sales 2020 42 034 M 50 174 M 50 174 M
Net income 2020 -10 295 M -12 288 M -12 288 M
Net Debt 2020 34 614 M 41 317 M 41 317 M
P/E ratio 2020 -4,44x
Yield 2020 4,46%
Sales 2021 42 284 M 50 472 M 50 472 M
Net income 2021 3 712 M 4 430 M 4 430 M
Net Debt 2021 33 417 M 39 888 M 39 888 M
P/E ratio 2021 13,5x
Yield 2021 4,42%
Capitalization 48 281 M 57 498 M 57 631 M
EV / Sales 2020 1,97x
EV / Sales 2021 1,93x
Nbr of Employees 100 618
Free-Float 100,0%
More Financials
Company
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Sales are distributed by product family as follows: - agrochemicals (45.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (41.2%) : intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc. ; - OTC... 
Sector
Pharmaceuticals
Calendar
02/25Earnings Release
More about the company
Notations Surperformance© of Bayer AG
Trading Rating : Investor Rating :
More Ratings
All news about BAYER AG
11/24BAYER : Film About Pivotal Canadian Patent Case Attracting Controversy
AQ
11/19BAYER : initiates new G4A Digital Health Partnerships Program
AQ
11/18BAYER : Finerenone showed consistent benefits on cardiovascular outcomes in pati..
AQ
11/13BAYER : Metagenomi closes USD 65 million Series A financing led by Leaps by Baye..
AQ
11/12BAYER : Invests in US Gene-Editing Company Metagenomi
DJ
11/12BAYER AG : Goldman Sachs reiterates its Buy rating
MD
11/12BAYER : Metagenomi closes USD 65 million Series A financing led by Leaps by Baye..
PU
11/10BAYER CROPSCIENCE LIMITED : reports Q2 results for FY 2020-21
AQ
11/09BAYER : makes 'substantial progress' in Roundup cancer lawsuits, mediator says
RE
11/09BAYER : Applies for US, EU Marketing Authorization for Finerenone
DJ
11/06Bayer executives buy 2.9 million euros in battered stock after writedowns
RE
11/05Regeneron Notches Higher 3Q Profit Amid Progress on Covid-19 Treatment
DJ
11/05BAYER AG : Bernstein gives a Buy rating
MD
11/05BAYER AG : Berenberg keeps its Buy rating
MD
11/05BAYER AG : JP Morgan reiterates its Neutral rating
MD
More news
News in other languages on BAYER AG
11/24Syngenta kündigt bienenfreundliches Insektizid an
11/20Aktien Frankfurt: Dax zum Wochenschluss wieder etwas höher (AF)
11/20La Bourse de Francfort finit la semaine dans le vert (Dax:+0,39%)
11/18BAYER : soutien à des jeunes pousses dans la santé numérique
11/17PRESSESTIMME : 'Münchner Merkur' zu Corona/Merkel
More news
Analyst Recommendations on BAYER AG
More recommendations
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | MarketScreener
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 61,28 €
Last Close Price 49,15 €
Spread / Highest target 73,0%
Spread / Average Target 24,7%
Spread / Lowest Target -6,40%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Norbert Winkeljohann Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-32.50%57 498
JOHNSON & JOHNSON-1.50%378 744
ROCHE HOLDING AG-4.28%281 946
PFIZER INC.-1.59%203 437
MERCK & CO., INC.-11.89%202 757
NOVARTIS AG-12.66%200 273